Divis Laboratories Ltd | DIVI - Ebit

Stock Price
6,274.00
Daily Change
-17.00 -0.27%
Monthly
3.60%
Yearly
10.02%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR7.72B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Aurobindo Pharma INR 12.43B 1.49B Dec/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lupin INR 18.97B 757M Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025